Cholecystectomy Devices Market (By Surgery Type: Laparoscopic, Open; By Indication: Cholecystitis, Pancreatitis; By End Use: Hospitals, ASCs; By Device) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2022-2030

The global cholecystectomy devices market was surpassed at USD 41.4 million in 2021 and is expected to hit around USD 86.2 million by 2030, growing at a CAGR of 8.49% from 2022 to 2030.

The industry is projected to be driven by the rising acceptance of elective laparoscopic surgery. For instance, laparoscopic cholecystectomy is one of the most frequently performed procedures, with almost 400,000 ambulatory laparoscopic cholecystectomies performed in the United States in 2019. Since the 1990s, laparoscopic cholecystectomy has been regarded as the preferred surgical procedure for treating gallstone disease. The advancement of cholecystectomy technologies is thought to be a significant market driver.

A number of major players are investing in R&D to introduce cutting-edge products. One significant development in the field is the introduction of medical robots that help surgeons during operations. Robotic surgery has lately gained acceptability and application in general surgery, and in specific gastrointestinal operations, it may provide superior results over laparoscopic surgery. Robotic cholecystectomy has been proven to be a secure and efficient procedure. According to reports, the robot has enhanced instrumentation, dexterity, and visualization during minimal access surgery. The industry is also being driven by the growing geriatric population as elderly people are more at risk for gallstone diseases.

People aged 70 years and above have an almost 50% chance of acquiring gallstones, whereas people under the age of 40 years have an about 8% chance of developing gallstones. In addition, due to an increased preference for laparoscopic operations and an increase in elective surgery volumes, the rate of cholecystectomy surgeries has grown by 60%. But, approximately, 10% of cholecystectomy patients experienced comparable post-surgery symptoms; this disorder is referred to as a post-cholecystectomy syndrome. Moreover, risks, such as infection of the surgical site, bile duct damage, retained gallstones, abscess formation, severe bleeding, and bile duct stenosis, may hamper the growth of the industry in the future.

Scope of The Report

Device Insights

On the basis of devices, the industry has been further segmented into conventional and robotic-assisted cholecystectomy surgery devices. The conventional surgical devices segment includes laparoscopes, energy systems, trocars, closure devices, suction/irrigation devices, insufflation devices, and hand access instruments, such as an electrode, scissors, dissectors, forceps, and grasper. The segment dominated the global industry in 2021 and accounted for the largest share of 90.08% of the total revenue. Among the conventional devices, the energy systems segment dominated the industry in 2021.

Energy systems allow rapid sequential tissue and vessel sealing, transection, and coagulation during laparoscopic cholecystectomy surgery. The laparoscope segment is expected to expand at the highest CAGR during the forecast period. A laparoscope is a small tool that has a tiny video camera and light on the end, which allows a surgeon to see inside the body without creating a larger opening. The robotic-assisted cholecystectomy surgery devices segment is expected to register the fastest CAGR during the forecast period. The robotic devices can manipulate tissue considerably more precisely than laparoscopic tools in the hands of an expert robotic surgeon.

As a result, there is a lower possibility of bleeding, bile leakage, and unintentional harm to surrounding tissues during surgery. About 3,000 incidences of common bile duct injury have been reported annually in the U.S. alone during the laparoscopic cholecystectomy era. It is conceivable that robotic cholecystectomy could lower this figure. The stated advantages of robotic-assisted cholecystectomy surgery devices include relatively shorter hospital stays and faster healing time with a noticeable reduction in post-operative pain. However, the lack of skilled professionals and the high cost of robotic devices explain the lower penetration rate and justify the lesser market size.

Surgery Type Insights

On the basis of surgery type, the global industry has been further segmented into laparoscopic cholecystectomy and open cholecystectomy. The laparoscopic cholecystectomy segment dominated the global industry in 2021 and accounted for the maximum share of more than 79.71% of the overall revenue. The laparoscopic cholecystectomy is conducted by inserting a small video camera in the abdomen with small incisions and usually takes one to two hours. Laparoscopic surgery has recently gained popularity due to its advantages, including a shorter hospital stay, less blood loss, and lower patient morbidity.

It also offers quick recovery, quick and successful outcomes, a low risk of infection, a small or no incision, and less pain. The demand for cholecystectomy devices is projected to increase during the forecast period since laparoscopic cholecystectomy surgery is in high demand. Moreover, open cholecystectomy is a conventional method used for the removal of the gallbladder, and it is only done where laparoscopic cholecystectomy surgery cannot be done safely. However, considerable factors, such as recent advancements in technology, increased preference for minimally invasive surgeries, longer postoperative hospital stays, excessive bleeding, and common bile duct injuries, have resulted in a slower growth rate and lesser market share of the segment.

Indication Insights

On the basis of indications, the global industry has been further categorized into indications, such as cholelithiasis, choledocholithiasis, cholecystitis, pancreatitis, and others. The cholecystitis segment dominated the global industry in 2021 and accounted for the largest share of more than 41.91% of the overall revenue. Cholecystitis is the condition where the gallbladder gets inflamed due to the presence of gallstones. The segment dominance is due to the high prevalence and incidence of cholecystitis. For instance, globally, the incidence rate of acute cholecystitis is around 6,300 per 100,000 in individuals below 50 years of age and 20,900 per 100,000 in individuals aged above 50 years.

The prevalence of acute cholecystitis is approximately 369 per 100,000 individuals in the United States. In addition, females are more commonly affected by gallstone diseases than males. Choledocholithiasis is expected to grow at the highest CAGR during the forecast period. Choledocholithiasis occurs when a gallstone blocks the common bile duct and bile cannot flow past it. It impedes the flow of bile from the liver to the intestine. Pressure rises resulting in elevation of liver enzymes and jaundice. It develops in about 10 to 20% of patients with gallbladder stones. Obesity, pregnancy, rapid weight loss, high fat diet, and a liver disorder are the major risk factors.

End-use Insights

Based on end-uses, the industry has been classified into hospitals, Ambulatory Surgical Centers (ASCs), and others. The hospital segment dominated the global industry in 2021 and accounted for the maximum share of more than 56.93% of the overall revenue. A rise in patients suffering from gallstone disorders and the resultant rise in surgical treatments are the factors responsible for segment expansion. Due to the simplicity of managing any crises that may develop during surgical procedures and the availability of a wide range of treatment options in such facilities, hospitals have a substantially larger patient inflow than other healthcare settings.

In addition, hospitals are the primary provider of healthcare in the majority of nations, therefore more laparoscopic procedures are performed there than in alternative healthcare facilities like clinics or surgery centers. As a result, compared to other end-use segments, the demand for laparoscopic devices is relatively high in hospitals. On the other hand, the ASCs segment is expected to witness the highest growth rate during the forecast period. The segment growth can be attributed to the rising interest in outpatient surgery, the adoption of minimally invasive treatments, and the affordability of ASC-based laparoscopic procedures. Furthermore, a high number of robotic-assisted procedures are carried out in outpatient facilities or ASCs.

Regional Insights

The industry is dominated by North America, which held a major revenue share of more than 36.6% in 2021. One of the main factors driving the region’s growth includes the high preference for laparoscopic cholecystectomy procedures over open cholecystectomy procedures. In addition, the market is impacted by the competition between well-known players in terms of product innovation. Laparoscopy is now preferred over traditional surgeries by surgeons since it encourages quick recovery and successful outcomes. Moreover, rising healthcare costs in the U.S. may encourage both new and established competitors to enter the industry.

For instance, according to the Centers for Medicaid and Medicare Services, U.S. healthcare spending was USD 4.1 trillion in 2020, or 19.7% of the country’s GDP, up 9.7% from 2019. In the Asia Pacific region, the market is expected to witness the fastest CAGR during the forecast period. This is owing to an increase in the number of advanced, well-equipped hospitals and a large volume of cholecystectomy surgical procedures. Gallstone diseases are comparatively less prevalent in developing countries. Among the developing countries, India and Taiwan have a higher prevalence of acute cholecystitis.

Australia and South Korea are some of the emerging economies in the Asia Pacific region. Advancing technology, increasing investments, improving reimbursement scenarios, and growing medical tourism is likely to drive the market in the region. Other driving factors include affordable devices, an increase in M&A activities, and supportive government initiatives to improve healthcare services. The government has made significant investments to provide basic health insurance to all citizens.

Key Players

• Surgical Holding
• B. Braun SE
• Surtex Instruments Ltd.
• Sklar Surgical Instruments
• Olympus
• Millennium Surgical
• Stryker Corporation
• Medtronic
• Intuitive Surgical
• GerMedUSA

Market Segmentation

• By Device Outlook
• Conventional Cholecystectomy Devices

• Laparoscopes
• Energy Systems
• Trocars
• Closure Devices
• Suction/ Irrigation Device
• Insufflation Device
• Hand Access Instruments
• Robotic-assisted Cholecystectomy Surgery Devices
• By Surgery Type Outlook
• Laparoscopic Cholecystectomy
• Open Cholecystectomy
• By Indication Outlook
• Cholelithiasis
• Choledocholithiasis
• Cholecystitis
• Pancreatitis
• Others
• By End-use Outlook
• Hospitals
• Ambulatory Surgical Centers
• Others
• By Regional Outlook
• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Italy
• Spain
• Russia
• Asia Pacific
• Japan
• China
• India
• Australia
• South Korea
• Latin America
• Mexico
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE
• Turkey